Amarin Corp. Plc (AMRN)
14.48
+0.23
(+1.61%)
USD |
NASDAQ |
Dec 11, 16:00
14.49
+0.01
(+0.07%)
After-Hours: 20:00
Amarin Research and Development Expense (Quarterly): 3.321M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Alkermes Plc | 80.34M |
| Jazz Pharmaceuticals Plc | 198.20M |
| Trinity Biotech Plc | 1.117M |
| DBV Technologies SA | 26.82M |
| Evaxion AS | 2.158M |